Roche Outlines ASR, Microarray Changes Made In Response To FDA Letter

Roche Diagnostic microarrays will be sold as research-use only tests until the firm is able to seek in vitro diagnostic status, Robert Gregg, PhD, director of regulatory submissions, explained during the American Association of Clinical Chemistry annual meeting in Los Angeles July 26